Heather Wakelee
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01515969) | Heather Wakelee | 2012-07-01 |
| A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies (NCT01364727) | Heather Wakelee | 2011-06-01 |
| Phase 2 Trial of Bevacizumab in Combination With Pemetrexed (NCT00227019) | Heather Wakelee | 2006-03-01 |
Track Heather Wakelee automatically
Every clearance here is in the API, with alerts when new ones post.